Email ID
Password
Scrip   
US moves closer to allowing emergency use of peramivir for H1N1
08 October 2009
Sue Sutter

The US government has moved a step closer to authorising emergency use of BioCryst Pharmaceuticals' investigational neuraminidase inhibitor peramivir for treating the new 2009 H1N1 influenza.
The US health and human services (HHS) department has added peramivir to the list of countermeasures...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36